NeuroQuestions
Release Date: June 1, 2017 Expiration Date: June 1, 2026
Content Review: April 26, 2017; June 17, 2020, May 2023
Estimated time to complete activity: Up to 235 hours
Overview:
NeuroQuestions helps subscribers prepare for their Neurology Knowledge Assessment Program exams, written boards, and recertification for boards. A question bank for neurology physicians provides up-to-date questions, and explanations with answers.
Target Audience:
The target audience consists of physicians specializing in neurology.
Accreditation and Designation:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Interstate Postgraduate Medical Association (IPMA) and NeuroQuestions. The IPMA is accredited by the ACCME to provide continuing medical education for physicians.
The Interstate Postgraduate Medical Association designates this enduring material for a maximum of 69 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, Neuroquestions has met the requirements as a MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:
MOC Part II CME Activity:
Psychiatry & Neurology
Commercial Support:
None
Disclosure Information:
As a provider dedicated to independent education and accredited by the ACCME, IPMA must ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. All individuals with potential to influence the content of this program have disclosed all financial relationships that have occurred in the past 24 months with ineligible companies. The disclosures have been reviewed according to policy and these declarations are listed below. All individuals with potential conflicts have been contacted as needed by IPMA staff, and issues of conflict have been discussed, managed, and mitigated.
Disclaimer:
The opinions expressed in the enduring educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
All reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education program. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the learner is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Approval of credit for this continuing education program does not imply endorsement by IPMA of any product or manufacturer identified.
Any medications or treatment methods suggested in this CME activity should not be used by the practitioner without evaluation of their patient's condition(s) and possible contraindication(s) or danger(s) of use of any specific medication.
|
Individual |
Role |
Disclosure |
|
Robert Bucelli, MD |
Faculty |
Advisory Board & Consultant: Biogen, Therapy Area: ALS |
|
Gabriela de Bruin, MD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Collin McClelland, MD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Heidi Ness |
Program Planning |
No relevant relationships with ineligible companies to disclose |
|
Gus Stern, MD |
Program Planning |
No relevant relationships with ineligible companies to disclose |
|
J. Richard Toleikis, PhD |
Content Review |
No relevant relationships with ineligible companies to disclose |
Privacy Policy:
At IPMA, we care about providing you with tools and information to manage and protect your online privacy. IPMA retains records solely for keeping records in accordance with ACCME policies. We will not share your information with any other organizations. We will keep you informed of our CME activities. Please e-mail cmehelp@ipmameded.org if you do not want to receive any communications from us.
Copyright:
© Copyright 2020 by NeuroQuestions. This also contains material copyrighted by third parties.
Contact Information:
IPMA
PO Box 5474
Madison, WI 53705
608.231.9045